BRCA1-related gene signature in breast cancer: The role of ER status and molecular type

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 1, 2011, Pages 125-136

  Lisowska, Katarzyna Marta ^a   Dudaladava, Volha ^a,b   Jarzab, Michal ^a   Huzarski, Tomasz ^c   Chmielik, Ewa ^a   Stobiecka, Ewa ^a   Lubinski, Jan ^c   Jarzab, Barbara ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b GRODNO STATE MEDICAL UNIVERSITY   (Belarus)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

BRCA1 gene mutation; ER status of the tumor; Gene expression signature; Hereditary breast cancer; Molecular subtypes of breast cancer

Indexed keywords

BRCA1 PROTEIN; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; STRATIFICATION; BREAST TUMOR; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BRCA1 PROTEIN; BREAST NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79957859297     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e227     Document Type: Article

References (27)

1. Breast Cancer Linkage Consortium: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349, 1505-10 (1997)
2. S. R. Lakhani, B. A. Gusterson, J. Jacquemier, J. P. Sloane, T. J. Anderson, M. J. van de Vijver, D. Venter, A. Freeman, A. Antoniou, L. McGuffog, E. Smyth, C. M. Steel, N. Haites, R. J. Scott, D. Goldgar, S. Neuhausen, P. A. Daly, W. Ormiston, R. McManus, S. Scherneck, B. A. Ponder, P. A. Futreal, J. Peto, D. Stoppa-Lyonnet, Y. J. Bignon, M. R. Stratton: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90, 1138-45 (1998) (Pubitemid 28380718)
3. M. J. van de Vijver: The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era: historical perspectives. Breast Cancer Res 1, 27-30 (1999)
4. L. S. Teng, Y. Zheng, H. H. Wang: BRCA1/2 associated hereditary breast cancer. J Zhejiang Univ Sci B 9, 85-9 (2008) (Pubitemid 351234292)
5. I. Hedenfalk, D. Duggan, Y. Chen, M. Radmacher, M. Bittner, R. Simon, P. Meltzer, B. Gusterson, M. Esteller, O. P. Kallioniemi, B. Wilfond, A. Borg, J. Trent, M. Raffeld, Z. Yakhini, A. Ben-Dor, E. Dougherty, J. Kononen, L. Bubendorf, W. Fehrle, S. Pittaluga, S. Gruvberger, N. Loman, O. Johannsson, H. Olsson, G. Sauter: Geneexpression profiles in hereditary breast cancer. N Engl J Med 344, 539-48 (2001) (Pubitemid 32167867)
6. L. J. van't Veer, H. Dai, M. J. van de Vijver, Y. D. He, A. A. Hart, R. Bernards, S. H. Friend: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-6 (2002) (Pubitemid 34130608)
7. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J. S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C. M. Perou, P.E . Lonning, P. O. Brown, A. L. Borresen-Dale, D. Botstein: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100, 8418- 23 (2003) (Pubitemid 36842560)
8. E. Grzybowska, H. Zientek, A. Jasinska, M. Rusin, P. Kozlowski, K. Sobczak, A. Sikorska, E. Kwiatkowska, L. Gorniak, E. Kalinowska, B. Utracka-Hutka, J. Wloch, E. Chmielik, W. J. Krzyzosiak: High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer. Hum Mutat 16, 482-90 (2000) (Pubitemid 32001297)
9. E. Grzybowska, M. Sieminska, H. Zientek, E. Kalinowska, J. Michalska, B. Utracka-Hutka, J. Rogozinska-Szczepka, M. Kazmierczak-Maciejewska: Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population. Acta Biochim Pol 49, 351-6 (2002) (Pubitemid 135686781)
10. B. Gorski, T. Byrski, T. Huzarski, A. Jakubowska, J. Menkiszak, J. Gronwald, A. Pluzanska, M. Bebenek, L. Fischer-Maliszewska, E. Grzybowska, S. A. Narod, J. Lubinski: Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66, 1963-8 (2000) (Pubitemid 30480103)
11. J. P. Struewing, P. Hartge, S. Wacholder, S. M. Baker, M. Berlin, M. McAdams, M. M. Timmerman, L. C. Brody, M. A. Tucker: The risk of cancer associated with specific mutations of BRCA 1 and BRCA 2 among Ashkenazi Jews. NEJM 336, 1401-1408 (1997) (Pubitemid 27208598)
12. P. Chomczynski and N. Sacchi: The single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162, 156-9 (1987) (Pubitemid 17064313)
13. M. Esteller, J. M. Silva, G. Dominguez, F. Bonilla, X. Matias-Guiu, E. Lerma, E. Bussaglia, J. Prat, I. C. Harkes, E. A. Repasky, E. Gabrielson, M. Schutte, S. B. Baylin, and J. G. Herman: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92, 564-569 (2000) (Pubitemid 30212318)
14. E. Matros, Z. C. Wang, G. Lodeiro, A. Miron, J. D. Iglehart, and A. L. Richardson: BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat 91, 179-186 (2005) (Pubitemid 40684930)
15. H. C. Kang, I. J. Kim, J. H. Park, Y. Shin, J. L. Ku, M. S. Jung, B. C. Yoo, H. K. Kim, J. G. Park: Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res 10 (1 Pt 1), 272-84 (2004) (Pubitemid 38114190)
16. R. Desper, J. Khan, A. A. Schaffer: Tumor classification using phylogenetic methods on expression data. J Theor Biol 228, 477-96 (2004) (Pubitemid 38726070)
17. B. Gorski, A. Jakubowska, T. Huzarski, T. Byrski, J. Gronwald, E. Grzybowska, A. Mackiewicz, M. Stawicka, M. Bebenek, D. Sorokin, L. Fiszer- Maliszewska, O. Haus, H. Janiszewska, S. Niepsuj, S. Gozdz, L. Zaremba, M. Posmyk, M. Pluzanska, E. Kilar, D. Czudowska, B. Wasko, R. Miturski, J. R. Kowalczyk, K. Urbanski, M. Szwiec, J. Koc, B. Debniak, A. Rozmiarek, T. Debniak, C. Cybulski, E. Kowalska, A. Toloczko-Grabarek, S. Zajaczek, J. Menkiszak, K. Medrek, B. Masojc, M. Mierzejewski, S. A. Narod, J. Lubinski: A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110, 683-6 (2004) (Pubitemid 38746026)
18. S. Gruvberger, M. Ringner, Y. Chen, S. Panavally, L. H. Saal, A. Borg, M. Ferno, C. Peterson, P. S. Meltzer: Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61, 5979-84 (2001) (Pubitemid 32762524)
19. A. Weisz, W. Basile, C. Scafoglio, L. Altucci, F. Bresciani, A. Facchiano, P. Sismondi, L. Cicatiello, M. De Bortoli: Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes. J Cell Physiol 200, 440-50 (2004) (Pubitemid 39006936)
20. V. N. Kristensen, T. Sorlie, J. Geisler, A. Langerod, N. Yoshimura, R. Karesen, N. Harada, P. E. Lonning, A. L. Borresen-Dale: Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications. Clin Cancer Res 11, 878-83 (2005)
21. S. Jia, A. Meng: Tob genes in development and homeostasis. Dev Dyn 236, 913-21 (2007) (Pubitemid 46641333)
22. T. Miyasaka, M. Morita, K. Ito, T. Suzuki, H. Fukuda, S. Takeda, J. Inoue, K. Semba, T. Yamamoto: Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. Cancer Sci 99, 755- 61 (2008) (Pubitemid 351448080)
23. N. Ezzeddine, T. C. Chang, W. Zhu, A. Yamashita, C. Y. Chen, Z. Zhong, Y. Yamashita, D. Zheng, A. B. Shyu: Human TOB, an antiproliferative transcription factor, is a poly (A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation. Mol Cell Biol 27, 7791-801 (2007) (Pubitemid 350086413)
24. Y. Jiao, C. M. Ge, Q.H. Meng, J. P. Cao, J. Tong, S. J. Fan: Adenovirus-mediated expression of Tob1 sensitizes breast cancer cells to ionizing radiation. Acta Pharmacol Sin 28, 1628-36 (2007) (Pubitemid 47493295)
25. S. R. Lakhani, J. S. Reis-Filho, L. Fulford, F. Penault-Llorca, M. van der Vijver, S. Parry, T. Bishop, J. Benitez, C. Rivas, Y. J. Bignon, J. Chang-Claude, U. Hamann, C. J. Cornelisse, P. Devilee, M. W. Beckmann, C. Nestle-Kramling, P. A. Daly, N. Haites, J. Varley, F. Lalloo, G. Evans, C. Maugard, H. Meijers-Heijboer, J. G. Klijn, E. Olah, B. A. Gusterson, S. Pilotti, P. Radice, S. Scherneck, H. Sobol, J. Jacquemier, T. Wagner, J. Peto, M. R. Stratton, L. McGuffog, D. F. Easton; Breast Cancer Linkage Consortium: Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11, 5175-80 (2005) (Pubitemid 41003703)
26. N. C. Turner, J. S. Reis-Filho: Basal-like breast cancer and the BRCA1 phenotype. Oncogene 25, 5846-53 (2006) (Pubitemid 44453440)
27. L. Da Silva, C. Clarke, S. R. Lakhani: Demystifying basal-like breast carcinomas. J Clin Pathol 60, 1328-32 (2007) (Pubitemid 350247248)